Stem cell therapy for Parkinson's is an exciting area, but it's still in early research stages. What has shown more promise recently are related approaches like gene therapy and growth factor protein treatments.
Here's a quick snapshot of what's being explored:
- Gene therapy (GAD & VY-AADC): Targets specific brain areas Show Full Answer
Stem cell therapy for Parkinson's is an exciting area, but it's still in early research stages. What has shown more promise recently are related approaches like gene therapy and growth factor protein treatments.
Here's a quick snapshot of what's being explored:
- Gene therapy (GAD & VY-AADC): Targets specific brain areas to boost dopamine availability, with some trials showing lasting symptom improvement
- GDNF growth factor therapy: Delivers proteins designed to restore failing dopamine-producing brain cells — early results described as "compelling"
- Deep Brain Stimulation (DBS): Already an established option that some MyParkinsonsTeam members have explored
These trials are small so far, and researchers are cautious but optimistic. Costs and long-term effects are still being studied. The best next step would be talking to a neurologist or movement disorder specialist about whether any current clinical trials might be a good fit. Websites like ClinicalTrials.gov are also a great place to search for active Parkinson's studies near you.
August 6
Continue with Facebook
Continue with Email
Join
Your Privacy Choices
